Overview

Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder

Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate if NS2359 is effective in the treatment of ADHD in adult patients.
Phase:
Phase 2
Details
Lead Sponsor:
NeuroSearch A/S